Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension
- 18 March 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 95 (6) , 1479-1486
- https://doi.org/10.1161/01.cir.95.6.1479
Abstract
Background Right heart failure is an important cause of morbidity and mortality in primary pulmonary hypertension. In a recent prospective, randomized study of severely symptomatic patients, treatm...Keywords
This publication has 32 references indexed in Scilit:
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991
- Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)Annals of Internal Medicine, 1990
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987
- Doppler echocardiography assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertensionJournal of the American College of Cardiology, 1986
- The Effect of Prostacyclin (PGI2) on Platelet Behaviour. Thrombus Formation in Vivo and Bleeding TimeThrombosis and Haemostasis, 1979
- Circulatory and anti-platelet effects of intravenous prostacyclin in healthy menPharmacological Research Communications, 1978
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Echocardiographic features of primary pulmonary hypertensionThe American Journal of Cardiology, 1974